Product References
Bud31-mediated alternative splicing is required for spermatogonial stem cell self-renewal and differentiation.
Cell death and differentiation
Qin J,Huang T,Wang Z,Zhang X,Wang J,Dang Q,Cui D,Wang X,Zhai Y,Zhao L,Lu G,Shao C,Li S,Liu H,Liu Z
Sun Jan 01 00:00:00 EST 2023
Bud31-mediated alternative splicing is required for spermatogonial stem cell self-renewal and differentiation.
Cell death and differentiation
Qin J,Huang T,Wang Z,Zhang X,Wang J,Dang Q,Cui D,Wang X,Zhai Y,Zhao L,Lu G,Shao C,Li S,Liu H,Liu Z
Sun Jan 01 00:00:00 EST 2023
Multi-omics approach reveals posttranscriptionally regulated genes are essential for human pluripotent stem cells.
iScience
Iwasaki M,Kawahara Y,Okubo C,Yamakawa T,Nakamura M,Tabata T,Nishi Y,Narita M,Ohta A,Saito H,Yamamoto T,Nakagawa M,Yamanaka S,Takahashi K
Fri May 20 00:00:00 EDT 2022
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Nature communications
Wang Z,Wang S,Qin J,Zhang X,Lu G,Liu H,Guo H,Wu L,Shender VO,Shao C,Kong B,Liu Z
Fri Oct 21 00:00:00 EDT 2022
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Nature communications
Wang Z,Wang S,Qin J,Zhang X,Lu G,Liu H,Guo H,Wu L,Shender VO,Shao C,Kong B,Liu Z
Fri Oct 21 00:00:00 EDT 2022
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Nature communications
Wang Z,Wang S,Qin J,Zhang X,Lu G,Liu H,Guo H,Wu L,Shender VO,Shao C,Kong B,Liu Z
Fri Oct 21 00:00:00 EDT 2022
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Nature communications
Wang Z,Wang S,Qin J,Zhang X,Lu G,Liu H,Guo H,Wu L,Shender VO,Shao C,Kong B,Liu Z
Fri Oct 21 00:00:00 EDT 2022
The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Nature
Hsu TY,Simon LM,Neill NJ,Marcotte R,Sayad A,Bland CS,Echeverria GV,Sun T,Kurley SJ,Tyagi S,Karlin KL,Dominguez-Vidaña R,Hartman JD,Renwick A,Scorsone K,Bernardi RJ,Skinner SO,Jain A,Orellana M,Lagisetti C,Golding I,Jung SY,Neilson JR,Zhang XH,Cooper TA,Webb TR,Neel BG,Shaw CA,Westbrook TF
Thu Sep 17 00:00:00 EDT 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Nature
Hsu TY,Simon LM,Neill NJ,Marcotte R,Sayad A,Bland CS,Echeverria GV,Sun T,Kurley SJ,Tyagi S,Karlin KL,Dominguez-Vidaña R,Hartman JD,Renwick A,Scorsone K,Bernardi RJ,Skinner SO,Jain A,Orellana M,Lagisetti C,Golding I,Jung SY,Neilson JR,Zhang XH,Cooper TA,Webb TR,Neel BG,Shaw CA,Westbrook TF
Thu Sep 17 00:00:00 EDT 2015